Facebook Instagram Linkedin Youtube
Home Tags Immunicum

Tag: Immunicum

Erik Manting, vd Mendus

BioStock Studio: Immunicum’s CEO on the company’s new therapeutic focus

Immunicum addresses essential challenges in cancer therapy

Positive preclinical results for Immunicum

Immunicum attacks cancer with an immune activation “bomb”

2019 marked steady progress for Immunicum’s ilixadencel

Immunicum presents positive MERECA Phase II data

Immunicum’s advancements with ilixadencel highlighted in year-end report

Annual report highlights Immunicum’s competitive advantages

FDA

Immunicum’s ilixadencel granted regenerative medicine advanced therapy designation from FDA

Immunicum’s immuno-oncology platform shares the spotlight at Cancer Progress conference

123Page 2 of 3
© BioStock 2024